North America Embolotherapy Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

No. of Pages: 169    |    Report Code: BMIRE00027551    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Embolotherapy Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Embolotherapy Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Embolotherapy Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Patient Preference for Minimally Invasive Procedures to Favor Market
5.2 Market Opportunities
  • 5.2.1 Increasing Number Of Research And Development Activities
5.3 Future Trends
  • 5.3.1 Growing Applications of Embolotherapy
5.4 Impact of Drivers and Restraints

6. North America Embolotherapy Market Regional Analysis

6.1 North America Embolotherapy Market Overview
6.2 North America Embolotherapy Market Revenue 2020-2028 (US$ Million)
6.3 North America Embolotherapy Market Forecast Analysis

7. North America Embolotherapy Market Analysis – by Product

7.1 Embolic Agent
  • 7.1.1 Overview
  • 7.1.2 Embolic Agent: North America Embolotherapy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Support Device
  • 7.2.1 Overview
  • 7.2.2 Support Device: North America Embolotherapy Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Embolotherapy Market Analysis – by Disease Indication

8.1 Cancer
  • 8.1.1 Overview
  • 8.1.2 Cancer: North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Peripheral Vascular Disease
  • 8.2.1 Overview
  • 8.2.2 Peripheral Vascular Disease: North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Neurological Disease
  • 8.3.1 Overview
  • 8.3.2 Neurological Disease: North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Urological and Nephrological Disorder
  • 8.4.1 Overview
  • 8.4.2 Urological and Nephrological Disorder: North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Gastrointestinal Disorder
  • 8.5.1 Overview
  • 8.5.2 Gastrointestinal Disorder: North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Embolotherapy Market Analysis – by Procedure

9.1 Transcatheter Arterial Embolization
  • 9.1.1 Overview
  • 9.1.2 Gastrointestinal Disorder: North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • 9.2.1 Overview
  • 9.2.2 Gastrointestinal Disorder: North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Transarterial Chemoembolization
  • 9.3.1 Overview
  • 9.3.2 Gastrointestinal Disorder: North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Embolotherapy Market – North America Analysis

10.1 North America
  • 10.1.1 North America Embolotherapy Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 North America Embolotherapy Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Embolotherapy Market Breakdown, by Product
    • 10.1.1.1.2 US: North America Embolotherapy Market Breakdown, by Disease Indication
    • 10.1.1.1.3 US: North America Embolotherapy Market Breakdown, by Procedure
  • 10.1.1.2 Canada: North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Embolotherapy Market Breakdown, by Product
    • 10.1.1.2.2 Canada: North America Embolotherapy Market Breakdown, by Disease Indication
    • 10.1.1.2.3 Canada: North America Embolotherapy Market Breakdown, by Procedure
  • 10.1.1.3 Mexico : North America Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Embolotherapy Market Breakdown, by Product
    • 10.1.1.3.2 Mexico : North America Embolotherapy Market Breakdown, by Disease Indication
    • 10.1.1.3.3 Mexico : North America Embolotherapy Market Breakdown, by Procedure

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Embolotherapy Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Boston Scientific Corporation
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Cook Medical LLC
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Johnson & Johnson
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Medtronic
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Acandis GmbH
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Balt USA LLC
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Stryker Corporation
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Guerbet LLC
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Terumo Corporation
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Embolotherapy Market

  1. Abbott Laboratories
  2. Boston Scientific Corporation
  3. Cook Medical LLC        
  4. Johnson & Johnson
  5. Medtronic
  6. Acandis GmbH  
  7. Balt USA LLC
  8. Stryker Corporation
  9. Guerbet LLC
  10. Terumo Corporation
north-america-embolotherapy-market